Century Therapeutics, Inc. (IPSC)

Endeavor Group Holdings Revenue

Century Therapeutics had revenue of $109.16M in the quarter ending March 31, 2025, with 12,667.72% growth. This brings the company's revenue in the last twelve months to $114.90M, up 8,286.72% year-over-year. In the year 2024, Century Therapeutics had annual revenue of $6.59M with 194.81% growth.

• Revenue (ttm): $114.90M
• Revenue Growth: +8,286.72%
• P/S Ratio: 0.39
• Revenue / Employee: $765,987
• Employees: 150
• Market Cap: 45.94M

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2024	6.59M	4.35M	194.81%
Dec 31, 2023	2.24M	-2.96M	-57.01%
Dec 31, 2022	5.20M	-	-
Dec 31, 2021	-	-	-
Dec 31, 2020	-	-	-

Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.